Caris Life Sciences, Inc. Financial Overview
Caris Life Sciences, Inc.'s market cap is currently $7.55B. The company's EPS TTM is $0.08; its P/E ratio is -11.03; Caris Life Sciences, Inc. is scheduled to report earnings on November 5, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
